Follicular lymphoma – Basic Information

Go back

Follicular lymphoma is a slow-growing cancer that affects certain white blood cells in the body’s immune system, typically appearing as painless swelling in the lymph nodes. Though it is the second most common type of non-Hodgkin lymphoma, many people live for years with this condition, and some may not need treatment right away.

Understanding Follicular Lymphoma Worldwide

Follicular lymphoma affects people differently across the globe. In the United States and Europe, roughly six new cases are diagnosed per 100,000 people each year. This makes it the second most common form of non-Hodgkin lymphoma in these regions, with approximately 15,000 to 20,000 new diagnoses annually in the United States alone. Between 20 and 30 percent of all non-Hodgkin lymphomas are follicular lymphoma.[1][2][3]

The disease is far more common in Western countries compared to other parts of the world. It appears less frequently in Asia and among African American populations. Studies from India show that follicular lymphoma represents only about 10 percent of all non-Hodgkin lymphomas there, suggesting significant geographic variation in how often this cancer occurs.[6]

Follicular lymphoma typically affects older adults. The average age at diagnosis is around 60 to 65 years old, though the exact age varies by region. In Western populations, the median age is about 55 years, while in India, patients tend to be younger, with a median age of 51 years. The condition is relatively uncommon in people under 20 years of age. When it does occur in children, it behaves very differently from the adult form and is often considered a separate disease.[1][6]

There are slight differences in how the disease affects men and women. In Western countries, the ratio of men to women with follicular lymphoma is approximately 1.2 to 1. However, in Indian populations, men are affected about twice as often as women, showing a male-to-female ratio of 2 to 1.[6]

What Causes This Type of Lymphoma

The exact cause of follicular lymphoma remains unknown to medical researchers. What doctors do understand is that the disease involves changes to certain white blood cells called B lymphocytes, which normally help fight infections by producing antibodies. In follicular lymphoma, these cells undergo genetic changes that transform them into cancer cells.[1][2]

Most cases of follicular lymphoma involve a specific genetic change. About 85 to 90 percent of people with this condition have a chromosomal abnormality called translocation (14;18). This means that pieces of two different chromosomes have swapped positions. The result of this swap is that a gene called BCL2 becomes overactive. The BCL2 gene normally helps control cell death, but when it’s overactive, it prevents cancer cells from dying when they should. This gives the abnormal cells a survival advantage, allowing them to multiply and accumulate over time.[6][7]

However, having this genetic change alone doesn’t cause follicular lymphoma. Scientists have found the same translocation in healthy people who never develop the disease. This suggests that additional genetic changes must occur before the cancer develops. These changes happen during a person’s lifetime rather than being inherited from parents, which is why follicular lymphoma is not passed down through families.[2][6]

The cancer cells in follicular lymphoma originate from structures called germinal centers, which are found inside lymph nodes. These are areas where B lymphocytes normally mature and learn to fight specific infections. When these cells become cancerous, they often continue to form groups that look like germinal centers or follicles, which is how the disease gets its name.[6][7]

Who Is at Higher Risk

Several factors may increase a person’s likelihood of developing follicular lymphoma, though the disease can occur in people without any known risk factors. Age is one of the most significant factors. The risk increases substantially as people get older, with most cases diagnosed in people over 60 years of age.[1][4]

Race and ethnicity appear to play a role in risk. White individuals are diagnosed with follicular lymphoma more often than people of Asian or African American descent. This difference may reflect both genetic factors and environmental exposures that vary among populations.[2][6]

Certain immune system conditions may increase risk. People living with HIV, rheumatoid arthritis, lupus, or celiac disease may have a higher chance of developing lymphoma, including follicular lymphoma. These are all conditions that affect how the immune system functions. Similarly, people who have received organ transplants and take medications to suppress their immune system may face increased risk, though the lymphomas associated with these situations are more often high-grade or aggressive types.[4][14]

Environmental exposures have been linked to lymphoma risk in some studies. Chemicals such as pesticides, herbicides like Agent Orange, and possibly certain hair dyes have been associated with lymphoma development, though the evidence connecting these specifically to follicular lymphoma is not definitive. Having a family history of lymphoma may also slightly increase risk, suggesting that inherited genetic factors could play some role.[4][14]

⚠️ Important
While these factors may increase risk, many people with follicular lymphoma have none of these risk factors. Conversely, having one or more risk factors does not mean a person will definitely develop the disease. The causes are complex and often involve multiple factors working together over time.

Signs and Symptoms to Watch For

Follicular lymphoma often develops slowly and silently. Many people have no symptoms at all when the disease is discovered. The condition might be found during routine blood work or imaging tests done for unrelated reasons. This absence of symptoms is one reason why most people are diagnosed when the disease has already spread to multiple areas of the body.[1][3][8]

The most common symptom, when it does occur, is painless swelling in the lymph nodes. These swellings may appear as lumps in the neck, armpit, or groin area. Unlike swollen lymph nodes caused by infections, which are usually tender and go away after a few weeks, the enlarged nodes in follicular lymphoma are typically painless and persist over time. They may come and go, sometimes shrinking without treatment and then growing again later.[1][3]

Some people experience what doctors call B symptoms. These include drenching night sweats that soak through clothing and bedding, fevers that come and go without any obvious infection, and significant weight loss without trying to lose weight. Specifically, losing more than 10 percent of body weight over six months is considered a concerning sign. These symptoms are grouped together because their presence can affect treatment decisions and the outlook for the disease.[1][3][8]

Fatigue is another symptom that many people with follicular lymphoma experience. This is not ordinary tiredness that improves with rest. It is a profound sense of exhaustion that can make even simple daily activities feel difficult. This fatigue can persist even after treatment and may be one of the most burdensome long-term effects of living with the condition.[1][19]

When follicular lymphoma affects the bone marrow, it can interfere with normal blood cell production. This might cause anemia (low red blood cell counts), leading to breathlessness and tiredness. Low platelet counts can result in easy bruising or bleeding. Some people may also experience recurring infections if their white blood cell counts are affected.[3][8]

Less commonly, follicular lymphoma can cause symptoms related to the specific organs it affects. If lymph nodes in the abdomen are enlarged, a person might feel full quickly when eating or experience abdominal discomfort. Shortness of breath can occur if enlarged lymph nodes in the chest press on airways or if fluid accumulates around the lungs.[3][4]

Prevention Strategies and Screening

Because the exact causes of follicular lymphoma are not fully understood, there are no proven ways to prevent the disease. Unlike some cancers where lifestyle changes or vaccinations can reduce risk, follicular lymphoma does not have clear preventive measures that everyone can follow.[1]

However, there are some general health practices that may support overall immune function and reduce cancer risk more broadly. Avoiding tobacco smoke is important. Studies have shown that smoking cigarettes may increase both the risk of developing follicular lymphoma and the risk of dying from the disease once diagnosed. Quitting smoking or never starting is beneficial for many aspects of health, including possibly reducing lymphoma risk.[18]

Limiting exposure to known chemical hazards may also be wise, though the evidence linking specific chemicals to follicular lymphoma is not definitive. People who work with pesticides, herbicides, or other potentially harmful substances should follow safety guidelines and use protective equipment when appropriate.[4][14]

For people with immune system disorders or those taking immune-suppressing medications, regular medical follow-up is important. While these conditions may increase lymphoma risk, they require ongoing management by healthcare providers who can monitor for any concerning changes.[4]

There is no routine screening test for follicular lymphoma recommended for the general population. Unlike breast cancer or colon cancer, where screening tests can detect disease in people without symptoms, follicular lymphoma does not have a similar screening approach. Instead, the focus is on being aware of potential symptoms and seeking medical attention if concerning signs develop, particularly if swollen lymph nodes persist for more than two to three weeks.[1][4]

How the Disease Affects the Body

Understanding what happens in the body when follicular lymphoma develops helps explain why the disease behaves the way it does. The process begins in the lymphatic system, which is part of the body’s immune defense network. This system includes lymph nodes, the spleen, bone marrow, and other organs. It contains a fluid called lymph that circulates throughout the body, carrying lymphocytes and other immune cells that fight infections.[3][8]

In follicular lymphoma, B lymphocytes in the germinal centers of lymph nodes undergo genetic changes. The most common change involves the BCL2 gene moving to a position where it becomes overactive. The BCL2 protein normally acts like a brake on cell death, but when there’s too much of it, cells that should die continue living. This doesn’t make the cells multiply faster than normal cells, but it allows them to accumulate because they don’t die when they should. This is why follicular lymphoma is typically slow-growing compared to other cancers.[6][7]

As these abnormal lymphocytes accumulate, they tend to cluster together in patterns that resemble normal follicles or germinal centers. This is visible under a microscope and is one of the key features that pathologists look for when diagnosing the disease. These clusters of cancer cells can grow within lymph nodes, causing them to enlarge, or they can spread to other organs.[1][7]

The cancer cells don’t stay in one place. They can travel through the lymphatic system and bloodstream to reach lymph nodes throughout the body and other organs. This is why most people are diagnosed with advanced-stage disease. The bone marrow is commonly affected, which can interfere with the production of normal blood cells. The spleen may also become enlarged as cancer cells accumulate there.[1][2]

Despite this spread, follicular lymphoma typically remains slow-growing or indolent. Many people can live for years without symptoms or with only mild symptoms. The cancer cells continue to multiply slowly, but they often don’t cause serious problems for extended periods. However, in about 2 to 3 percent of cases each year, the disease can transform into a more aggressive type of lymphoma called diffuse large B-cell lymphoma. When this happens, the cancer begins growing much faster and requires more intensive treatment.[2][7]

The slow growth pattern means that follicular lymphoma behaves more like a chronic disease than an acute illness. It can wax and wane over time, sometimes appearing to improve on its own before worsening again. This behavior is different from many other cancers and influences how doctors approach treatment decisions.[3][12]

⚠️ Important
The slow-growing nature of follicular lymphoma means that not everyone needs immediate treatment. Some people can be monitored with regular checkups, an approach called active surveillance or “watch and wait.” Treatment is started only when symptoms develop or the disease shows signs of progression. This approach has been shown to result in similar survival outcomes as treating everyone immediately at diagnosis.

Ongoing Clinical Trials on Follicular lymphoma

  • Study of loncastuximab tesirine and epcoritamab combination treatment for patients with relapsed or refractory diffuse large B-cell lymphoma

    Recruiting

    1 1 1
    Germany
  • Study of dapagliflozin to prevent heart complications during lymphoma treatment in patients receiving first-line therapy

    Recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Denmark
  • Study Comparing Golcadomide and Rituximab with Other Treatments for Patients with Relapsed or Refractory Follicular Lymphoma

    Recruiting

    1 1 1 1
    Investigated diseases:
    Finland France Germany Greece Italy The Netherlands +2
  • Study on Rituximab, Lenalidomide, and Tafasitamab for Treating High-Risk and Low-Risk Follicular Lymphoma Patients

    Recruiting

    1 1 1
    Investigated diseases:
    Denmark Finland Iceland Norway Sweden
  • Study of tazemetostat combined with lenalidomide and rituximab in adult patients with relapsed or refractory follicular lymphoma

    Recruiting

    1 1 1
    Investigated diseases:
    Belgium France Germany Hungary Italy Poland +1
  • Study on CLIC-1901 CAR T-cells and Tocilizumab for Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and B-cell Non-Hodgkin Lymphoma

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark
  • Study on Early Stage Follicular Lymphoma: Evaluating Radiotherapy with Rituximab or Obinutuzumab for Patients with Early Stage Nodal Follicular Lymphoma

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany
  • Study on Mosunetuzumab and Lenalidomide for Patients with Untreated Follicular Lymphoma

    Recruiting

    1 1 1 1
    Investigated diseases:
    Austria Belgium France Germany Portugal Spain
  • Study Comparing Odronextamab and Lenalidomide with Rituximab and Lenalidomide for Patients with Relapsed/Refractory Follicular and Marginal Zone Lymphoma

    Recruiting

    1 1 1 1
    Austria Belgium Czechia France Germany Italy +2
  • Study on Safe Skin Test Concentrations for Biotherapy Allergies in Patients with Cancer Using Atezolizumab, Daratumumab, and Nivolumab

    Not yet recruiting

    1 1 1 1
    France

References

https://www.mayoclinic.org/diseases-conditions/follicular-lymphoma/symptoms-causes/syc-20584732

https://my.clevelandclinic.org/health/diseases/22606-follicular-lymphoma

https://lymphoma.org/understanding-lymphoma/aboutlymphoma/nhl/follicular-lymphoma/

https://www.webmd.com/cancer/lymphoma/follicular-lymphoma

https://bloodcancer.org.uk/understanding-blood-cancer/lymphoma/follicular-lymphoma/

https://www.ncbi.nlm.nih.gov/books/NBK538206/

https://en.wikipedia.org/wiki/Follicular_lymphoma

https://www.cancerresearchuk.org/about-cancer/non-hodgkin-lymphoma/types/follicular-lymphoma

https://www.mayoclinic.org/diseases-conditions/follicular-lymphoma/diagnosis-treatment/drc-20584747

https://lymphoma.org/understanding-lymphoma/aboutlymphoma/nhl/follicular-lymphoma/fltreatment/

https://pmc.ncbi.nlm.nih.gov/articles/PMC9490109/

https://ehoonline.biomedcentral.com/articles/10.1186/s40164-024-00551-1

https://bloodcancer.org.uk/understanding-blood-cancer/lymphoma/follicular-lymphoma/follicular-lymphoma-treatment-side-effects/

https://emedicine.medscape.com/article/203268-overview

https://www.theflf.org/your-support-hub/understanding-fl/treatment/

https://www.theflf.org/blog/coping-strategies-and-support-resources-for-navigating-life-with-follicular-lymphoma/

https://www.mdanderson.org/cancerwise/for-follicular-lymphoma-survivor–treatment-options-and-time-are-on-her-side.h00-159381945.html

https://www.webmd.com/cancer/lymphoma/strengthen-body-follicular-lymphoma

https://www.ipsen.com/oncology/debbie-living-every-moment-with-follicular-lymphoma/

https://lymphoma.org/storiesofhope/julianasoh/

https://www.mylymphomateam.com/resources/tips-to-overcome-fatigue-with-follicular-lymphoma

https://www.theflf.org/your-support-hub/living-well-with-fl/wellbeing/

https://lymphoma-action.org.uk/about-lymphoma/living-and-beyond-lymphoma

https://my.clevelandclinic.org/health/diseases/22606-follicular-lymphoma

https://medlineplus.gov/diagnostictests.html

https://www.questdiagnostics.com/

https://www.healthdirect.gov.au/diagnostic-tests

https://www.who.int/health-topics/diagnostics

https://pmc.ncbi.nlm.nih.gov/articles/PMC6558629/

https://www.yalemedicine.org/clinical-keywords/diagnostic-testsprocedures

https://www.health.harvard.edu/diagnostic-tests-and-medical-procedures

FAQ

Can follicular lymphoma be cured?

Follicular lymphoma is generally not considered curable with current treatments, though this is changing with newer therapies. However, many people live for many years with the disease, often dying with it rather than from it. The disease is managed more like a chronic condition that can be controlled with treatment when needed.

Why don’t some people with follicular lymphoma need treatment right away?

Because follicular lymphoma grows slowly and may not cause symptoms for years, research has shown that people who start treatment immediately don’t live longer than those who wait until symptoms develop. This “watch and wait” approach, called active surveillance, involves regular monitoring and starting treatment only when necessary.

Is follicular lymphoma hereditary?

No, follicular lymphoma is not inherited from parents. The genetic changes that cause it happen during a person’s lifetime rather than being passed down through families. However, having a family history of lymphoma may slightly increase risk, suggesting some genetic factors could play a role.

What does it mean if follicular lymphoma transforms?

Transformation occurs when slow-growing follicular lymphoma changes into a more aggressive type of lymphoma, usually diffuse large B-cell lymphoma. This happens in about 2 to 3 percent of cases each year. When transformation occurs, the cancer grows faster and requires more intensive treatment. Signs may include rapidly growing lymph nodes, new symptoms, or worsening of existing symptoms.

Why is follicular lymphoma more common in Western countries?

The reasons for geographic differences in follicular lymphoma rates are not fully understood. They likely involve a combination of genetic factors, environmental exposures, and possibly lifestyle differences between populations. The disease occurs much more frequently in the United States and Europe than in Asia or other parts of the world.

🎯 Key takeaways

  • Follicular lymphoma is the second most common type of non-Hodgkin lymphoma, with 15,000 to 20,000 new cases diagnosed yearly in the United States
  • Most people are diagnosed in their 60s, and the disease is more common in white populations than in Asian or African American groups
  • The hallmark genetic change involves a translocation that causes the BCL2 gene to become overactive, preventing cancer cells from dying normally
  • Many people have no symptoms at diagnosis, with the disease often found incidentally during routine tests
  • Painless swelling of lymph nodes in the neck, armpit, or groin is the most common symptom when present
  • Because it grows slowly, many people don’t need immediate treatment and can be monitored with active surveillance
  • The disease can transform into a more aggressive lymphoma in 2 to 3 percent of cases each year
  • There are no proven prevention strategies, though avoiding tobacco smoke may help reduce risk